phenylethanolamines

Phenylethanolamines are a class of organic compounds based on the phenethylamine skeleton that feature a hydroxyl group on the side chain, forming beta-hydroxyphenethylamines. They typically possess a substituted benzene ring and a side chain ending in an amino group, with variations in the ring substituents and on the nitrogen. A prominent subset within this class are the catecholamines, which carry a catechol (benzene–diol) moiety, such as norepinephrine and epinephrine.

Representative examples and natural occurrence: The most familiar phenylethanolamines are the endogenous neurotransmitters and hormones norepinephrine and epinephrine, which act on adrenergic receptors to regulate cardiovascular and metabolic responses. Other pharmacologically important members include synthetic or plant-derived compounds such as ephedrine and pseudoephedrine, used as decongestants and stimulants. The broader category may also encompass related alkaloids and synthetic drugs that share the beta-hydroxyphenethylamine backbone.

Biosynthesis and structure-activity relationships: In biological systems, phenylethanolamines arise from the tyrosine pathway, with enzymes converting tyrosine to L-DOPA, dopamine, norepinephrine, and, in certain cells, epinephrine. The presence and position of substituents on the ring, as well as substitutions on the nitrogen and side chain, influence receptor affinity and pharmacological effects, particularly binding to alpha and beta adrenergic receptors.

Pharmacology and applications: As a class, phenylethanolamines exert sympathetic nervous system effects, including increased heart rate, vasoconstriction, bronchodilation, and metabolic changes. They are used clinically as vasopressors and in emergency medicine (norepinephrine and epinephrine) or as decongestants and stimulants in various preparations (pseudoephedrine, phenylephrine). Safety profiles vary widely, with potential cardiovascular risks and regulatory controls on certain members.